William J. Gradishar MD

William J. Gradishar, MD, is the Betsy Bramsen Professor of Breast Oncology, Professor of Medicine, and Chief in the Division of Hematology and Medical Oncology at the Feinberg School of Medicine at Northwestern University. Dr. Gradishar also serves as Deputy Director for the Clinical Network of the Robert H. Lurie Comprehensive Cancer Center, where he also acts as Director of the Maggie Daley Center for Women’s Cancer Care. Additionally, he has served as Chair of the Annual Lynn Sage Comprehensive Breast Cancer Symposium since its inception.

Dr. Gradishar earned his medical degree from the University of Illinois Abraham School of Medicine. He later completed a residency and chief residency in internal medicine at Michael Reese Hospital and Medical Center and a fellowship in medical oncology at the University of Chicago. He is board-certified in internal medicine and medical oncology.

Dr. Gradishar specializes in the area of breast cancer therapeutics, with a focus on new endocrine therapy, chemotherapy, and biologic agents. He is a Fellow of the American College of Physicians and the American Society of Clinical Oncology (ASCO). He also is a member of the American Association for Cancer Research, the American Federation for Clinical Research, and the Association of Subspecialty Professors. Additionally, Dr. Gradishar serves as a consultant to the FDA’s Oncology Drug Advisory Committee.

Dr. Gradishar is past-Chair of several ASCO committees, including the Nominating Committee, the Professional Development Committee, the Oncology Training Program Committee, and the Communications Committee. He also previously served on the Committee on Cancer for the American College of Surgeons, as well as numerous study sections, including NIH, NCI, ACS, Komen, and the Alberta Cancer Board.

In addition to his professional memberships, Dr. Gradishar is an editorial board member for numerous journals, including Journal of Clinical Oncology, Oncology, Clinical Breast Cancer, Journal Watch, European Journal of Clinical and Medical Oncology, Clinical Cancer Research, and JNCCN–Journal of the National Comprehensive Cancer Network.

Dr. Gradishar is Chair of the NCCN Breast Cancer Panel and a member of the NCCN Breast Cancer Risk Reduction Panel. He also has participated on several committees for the NCCN Oncology Research Program.